Annual FCF
$5.06 B
-$2.75 B-35.17%
31 December 2023
Summary:
Abbott Laboratories annual free cash flow is currently $5.06 billion, with the most recent change of -$2.75 billion (-35.17%) on 31 December 2023. During the last 3 years, it has fallen by -$665.00 million (-11.62%). ABT annual FCF is now -41.50% below its all-time high of $8.65 billion, reached on 31 December 2021.ABT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$2.15 B
+$722.00 M+50.60%
30 September 2024
Summary:
Abbott Laboratories quarterly free cash flow is currently $2.15 billion, with the most recent change of +$722.00 million (+50.60%) on 30 September 2024. Over the past year, it has increased by +$832.00 million (+63.17%). ABT quarterly FCF is now -31.10% below its all-time high of $3.12 billion, reached on 31 December 2020.ABT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$6.49 B
+$832.00 M+14.72%
30 September 2024
Summary:
Abbott Laboratories TTM free cash flow is currently $6.49 billion, with the most recent change of +$832.00 million (+14.72%) on 30 September 2024. Over the past year, it has increased by +$1.99 billion (+44.39%). ABT TTM FCF is now -30.36% below its all-time high of $9.31 billion, reached on 30 September 2021.ABT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABT Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -35.2% | +63.2% | +44.4% |
3 y3 years | -11.6% | -4.1% | -30.4% |
5 y5 years | +3.1% | +38.9% | +70.1% |
ABT Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -41.5% | at low | -12.4% | +242.7% | -30.4% | +44.4% |
5 y | 5 years | -41.5% | +12.5% | -31.1% | +505.4% | -30.4% | +70.1% |
alltime | all time | -41.5% | +1225.7% | -31.1% | +671.6% | -30.4% | >+9999.0% |
Abbott Laboratories Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2.15 B(+50.6%) | $6.49 B(+14.7%) |
June 2024 | - | $1.43 B(+127.6%) | $5.65 B(+14.8%) |
Mar 2024 | - | $627.00 M(-72.5%) | $4.92 B(-2.7%) |
Dec 2023 | $5.06 B(-35.2%) | $2.28 B(+73.3%) | $5.06 B(+12.6%) |
Sept 2023 | - | $1.32 B(+89.2%) | $4.49 B(-18.1%) |
June 2023 | - | $696.00 M(-8.8%) | $5.49 B(-19.6%) |
Mar 2023 | - | $763.00 M(-55.5%) | $6.82 B(-12.6%) |
Dec 2022 | $7.80 B(-9.8%) | $1.72 B(-25.8%) | $7.80 B(-8.6%) |
Sept 2022 | - | $2.31 B(+13.9%) | $8.54 B(+0.9%) |
June 2022 | - | $2.03 B(+16.5%) | $8.47 B(+3.9%) |
Mar 2022 | - | $1.74 B(-28.9%) | $8.15 B(-5.7%) |
Dec 2021 | $8.65 B(+51.1%) | $2.45 B(+9.5%) | $8.65 B(-7.2%) |
Sept 2021 | - | $2.24 B(+30.6%) | $9.31 B(+7.8%) |
June 2021 | - | $1.72 B(-23.4%) | $8.64 B(+13.6%) |
Mar 2021 | - | $2.24 B(-28.2%) | $7.61 B(+32.9%) |
Dec 2020 | $5.72 B(+27.3%) | $3.12 B(+98.7%) | $5.72 B(+24.8%) |
Sept 2020 | - | $1.57 B(+130.9%) | $4.59 B(+0.5%) |
June 2020 | - | $680.00 M(+91.5%) | $4.56 B(+2.0%) |
Mar 2020 | - | $355.00 M(-82.1%) | $4.48 B(-0.5%) |
Dec 2019 | $4.50 B(-8.3%) | $1.98 B(+28.1%) | $4.50 B(+17.9%) |
Sept 2019 | - | $1.55 B(+161.3%) | $3.81 B(-6.9%) |
June 2019 | - | $592.00 M(+57.0%) | $4.10 B(-8.0%) |
Mar 2019 | - | $377.00 M(-71.0%) | $4.45 B(-9.3%) |
Dec 2018 | $4.91 B(+10.6%) | $1.30 B(-29.0%) | $4.91 B(+0.1%) |
Sept 2018 | - | $1.83 B(+93.3%) | $4.90 B(+1.8%) |
June 2018 | - | $946.00 M(+13.6%) | $4.82 B(-3.0%) |
Mar 2018 | - | $833.00 M(-35.7%) | $4.97 B(+12.0%) |
Dec 2017 | $4.43 B(+113.0%) | $1.29 B(-25.7%) | $4.43 B(+11.1%) |
Sept 2017 | - | $1.74 B(+58.9%) | $3.99 B(+26.5%) |
June 2017 | - | $1.10 B(+262.9%) | $3.15 B(+16.0%) |
Mar 2017 | - | $302.00 M(-64.5%) | $2.72 B(+30.6%) |
Dec 2016 | $2.08 B(+12.2%) | $851.00 M(-6.0%) | $2.08 B(+15.0%) |
Sept 2016 | - | $905.00 M(+36.7%) | $1.81 B(+7.2%) |
June 2016 | - | $662.00 M(-297.0%) | $1.69 B(-3.6%) |
Mar 2016 | - | -$336.00 M(-157.9%) | $1.75 B(-5.5%) |
Dec 2015 | $1.86 B(-28.6%) | $580.00 M(-26.0%) | $1.86 B(-16.7%) |
Sept 2015 | - | $784.00 M(+8.1%) | $2.23 B(-5.9%) |
June 2015 | - | $725.00 M(-411.2%) | $2.37 B(+3.6%) |
Mar 2015 | - | -$233.00 M(-124.5%) | $2.28 B(-12.1%) |
Dec 2014 | $2.60 B(+19.2%) | $951.00 M(+2.9%) | $2.60 B(-12.5%) |
Sept 2014 | - | $924.00 M(+43.9%) | $2.97 B(+29.7%) |
June 2014 | - | $642.00 M(+692.6%) | $2.29 B(+10.4%) |
Mar 2014 | - | $81.00 M(-93.9%) | $2.07 B(-4.8%) |
Dec 2013 | $2.18 B(-71.0%) | $1.32 B(+439.6%) | $2.18 B(+10.4%) |
Sept 2013 | - | $245.00 M(-42.5%) | $1.97 B(-58.2%) |
June 2013 | - | $426.00 M(+129.0%) | $4.72 B(-20.5%) |
Mar 2013 | - | $186.00 M(-83.3%) | $5.93 B(-21.1%) |
Dec 2012 | $7.52 B(+0.5%) | $1.12 B(-62.6%) | $7.52 B(-0.1%) |
Sept 2012 | - | $2.99 B(+82.1%) | $7.53 B(+5.4%) |
June 2012 | - | $1.64 B(-7.3%) | $7.14 B(-6.4%) |
Mar 2012 | - | $1.77 B(+57.2%) | $7.63 B(+2.0%) |
Dec 2011 | $7.48 B(-3.1%) | $1.13 B(-56.7%) | $7.48 B(-10.7%) |
Sept 2011 | - | $2.60 B(+22.2%) | $8.38 B(+3.2%) |
June 2011 | - | $2.13 B(+31.5%) | $8.12 B(+0.7%) |
Mar 2011 | - | $1.62 B(-20.0%) | $8.06 B(+4.4%) |
Dec 2010 | $7.72 B(+24.8%) | $2.03 B(-13.6%) | $7.72 B(+6.0%) |
Sept 2010 | - | $2.34 B(+12.9%) | $7.28 B(-4.7%) |
June 2010 | - | $2.07 B(+62.4%) | $7.64 B(+8.9%) |
Mar 2010 | - | $1.28 B(-19.5%) | $7.02 B(+13.4%) |
Dec 2009 | $6.19 B(+8.4%) | $1.59 B(-41.2%) | $6.19 B(+11.1%) |
Sept 2009 | - | $2.70 B(+86.2%) | $5.57 B(+6.2%) |
June 2009 | - | $1.45 B(+224.9%) | $5.24 B(+1.2%) |
Mar 2009 | - | $446.57 M(-53.9%) | $5.18 B(-9.2%) |
Dec 2008 | $5.71 B(+61.8%) | $967.99 M(-59.3%) | $5.71 B(+6.5%) |
Sept 2008 | - | $2.38 B(+71.4%) | $5.36 B(+29.7%) |
June 2008 | - | $1.39 B(+42.8%) | $4.13 B(+9.5%) |
Mar 2008 | - | $972.17 M(+56.5%) | $3.77 B(+6.9%) |
Dec 2007 | $3.53 B | $621.31 M(-46.0%) | $3.53 B(-9.1%) |
Sept 2007 | - | $1.15 B(+11.8%) | $3.88 B(+5.9%) |
June 2007 | - | $1.03 B(+41.5%) | $3.66 B(-4.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $727.17 M(-25.4%) | $3.83 B(-4.0%) |
Dec 2006 | $3.99 B(+0.6%) | $974.42 M(+4.5%) | $3.99 B(-1.6%) |
Sept 2006 | - | $932.55 M(-22.1%) | $4.06 B(-5.4%) |
June 2006 | - | $1.20 B(+35.0%) | $4.29 B(-7.9%) |
Mar 2006 | - | $886.87 M(-14.7%) | $4.65 B(+17.3%) |
Dec 2005 | $3.97 B(+24.9%) | $1.04 B(-10.6%) | $3.97 B(+15.6%) |
Sept 2005 | - | $1.16 B(-25.7%) | $3.43 B(+24.2%) |
June 2005 | - | $1.56 B(+684.0%) | $2.76 B(+15.9%) |
Mar 2005 | - | $199.58 M(-60.4%) | $2.38 B(-24.9%) |
Dec 2004 | $3.18 B(+26.9%) | $503.77 M(+2.0%) | $3.18 B(+5.6%) |
Sept 2004 | - | $493.86 M(-58.4%) | $3.01 B(-7.9%) |
June 2004 | - | $1.19 B(+19.6%) | $3.26 B(+15.1%) |
Mar 2004 | - | $991.75 M(+194.8%) | $2.84 B(+13.3%) |
Dec 2003 | $2.50 B(-13.3%) | $336.44 M(-55.2%) | $2.50 B(-16.0%) |
Sept 2003 | - | $750.62 M(-1.0%) | $2.98 B(+5.6%) |
June 2003 | - | $757.88 M(+15.2%) | $2.82 B(+4.2%) |
Mar 2003 | - | $658.10 M(-19.1%) | $2.71 B(-6.3%) |
Dec 2002 | $2.89 B(+20.1%) | $813.33 M(+37.5%) | $2.89 B(+11.1%) |
Sept 2002 | - | $591.32 M(-8.1%) | $2.60 B(-6.6%) |
June 2002 | - | $643.29 M(-23.3%) | $2.78 B(+8.6%) |
Mar 2002 | - | $838.70 M(+59.7%) | $2.56 B(+6.5%) |
Dec 2001 | $2.40 B(+16.4%) | $525.29 M(-32.1%) | $2.40 B(+2.5%) |
Sept 2001 | - | $774.16 M(+83.5%) | $2.34 B(+14.3%) |
June 2001 | - | $421.90 M(-38.1%) | $2.05 B(-21.3%) |
Mar 2001 | - | $681.79 M(+46.1%) | $2.61 B(+26.3%) |
Dec 2000 | $2.06 B(+19.1%) | $466.55 M(-2.9%) | $2.06 B(+42.2%) |
Sept 2000 | - | $480.48 M(-50.9%) | $1.45 B(-14.7%) |
June 2000 | - | $978.55 M(+608.3%) | $1.70 B(+34.7%) |
Mar 2000 | - | $138.16 M(-195.0%) | $1.26 B(-27.1%) |
Dec 1999 | $1.73 B(+12.7%) | -$145.42 M(-119.9%) | $1.73 B(-17.2%) |
Sept 1999 | - | $730.82 M(+35.4%) | $2.09 B(+112.0%) |
June 1999 | - | $539.77 M(-11.3%) | $987.86 M(-34.3%) |
Mar 1999 | - | $608.23 M(+181.8%) | $1.50 B(-2.3%) |
Dec 1998 | $1.54 B(+6.0%) | $215.80 M(-157.4%) | $1.54 B(+2.9%) |
Sept 1998 | - | -$375.94 M(-135.6%) | $1.49 B(-16.2%) |
June 1998 | - | $1.05 B(+64.0%) | $1.78 B(+36.3%) |
Mar 1998 | - | $643.00 M(+272.3%) | $1.31 B(-9.8%) |
Dec 1997 | $1.45 B(+1.2%) | $172.70 M(-300.6%) | $1.45 B(-8.3%) |
Sept 1997 | - | -$86.11 M(-114.9%) | $1.58 B(-24.0%) |
June 1997 | - | $579.28 M(-26.2%) | $2.08 B(+17.9%) |
Mar 1997 | - | $784.63 M(+158.8%) | $1.76 B(+23.0%) |
Dec 1996 | $1.43 B(-27.1%) | $303.13 M(-26.4%) | $1.43 B(-7.0%) |
Sept 1996 | - | $411.87 M(+56.2%) | $1.54 B(-6.5%) |
June 1996 | - | $263.70 M(-42.0%) | $1.65 B(-13.8%) |
Mar 1996 | - | $454.40 M(+10.5%) | $1.91 B(-2.7%) |
Dec 1995 | $1.97 B(-11.1%) | $411.18 M(-20.8%) | $1.97 B(-8.4%) |
Sept 1995 | - | $519.18 M(-1.5%) | $2.15 B(-3.6%) |
June 1995 | - | $526.89 M(+3.7%) | $2.23 B(+2.5%) |
Mar 1995 | - | $508.33 M(-14.1%) | $2.17 B(-1.7%) |
Dec 1994 | $2.21 B(+19.8%) | $591.69 M(-1.5%) | $2.21 B(-20.7%) |
Sept 1994 | - | $600.46 M(+26.9%) | $2.79 B(+10.8%) |
June 1994 | - | $473.14 M(-13.5%) | $2.52 B(+16.0%) |
Mar 1994 | - | $546.85 M(-53.2%) | $2.17 B(+17.5%) |
Dec 1993 | $1.85 B(+384.0%) | $1.17 B(+255.8%) | $1.85 B(+109.7%) |
Sept 1993 | - | $328.60 M(+162.9%) | $880.80 M(+54.3%) |
June 1993 | - | $125.00 M(-44.2%) | $571.00 M(+3.0%) |
Mar 1993 | - | $224.20 M(+10.4%) | $554.30 M(+45.3%) |
Dec 1992 | $381.60 M(-44.1%) | $203.00 M(+979.8%) | $381.60 M(+18.5%) |
Sept 1992 | - | $18.80 M(-82.6%) | $322.00 M(-39.2%) |
June 1992 | - | $108.30 M(+110.3%) | $530.00 M(-17.6%) |
Mar 1992 | - | $51.50 M(-64.1%) | $643.10 M(-5.8%) |
Dec 1991 | $682.60 M(+22.0%) | $143.40 M(-36.8%) | $682.60 M(-6.4%) |
Sept 1991 | - | $226.80 M(+2.4%) | $729.00 M(+1.5%) |
June 1991 | - | $221.40 M(+143.3%) | $718.50 M(+22.3%) |
Mar 1991 | - | $91.00 M(-52.1%) | $587.70 M(+5.0%) |
Dec 1990 | $559.50 M(+44.6%) | $189.80 M(-12.3%) | $559.50 M(+51.3%) |
Sept 1990 | - | $216.30 M(+138.7%) | $369.70 M(+141.0%) |
June 1990 | - | $90.60 M(+44.3%) | $153.40 M(+144.3%) |
Mar 1990 | - | $62.80 M | $62.80 M |
Dec 1989 | $386.80 M | - | - |
FAQ
- What is Abbott Laboratories annual free cash flow?
- What is the all time high annual FCF for Abbott Laboratories?
- What is Abbott Laboratories annual FCF year-on-year change?
- What is Abbott Laboratories quarterly free cash flow?
- What is the all time high quarterly FCF for Abbott Laboratories?
- What is Abbott Laboratories quarterly FCF year-on-year change?
- What is Abbott Laboratories TTM free cash flow?
- What is the all time high TTM FCF for Abbott Laboratories?
- What is Abbott Laboratories TTM FCF year-on-year change?
What is Abbott Laboratories annual free cash flow?
The current annual FCF of ABT is $5.06 B
What is the all time high annual FCF for Abbott Laboratories?
Abbott Laboratories all-time high annual free cash flow is $8.65 B
What is Abbott Laboratories annual FCF year-on-year change?
Over the past year, ABT annual free cash flow has changed by -$2.75 B (-35.17%)
What is Abbott Laboratories quarterly free cash flow?
The current quarterly FCF of ABT is $2.15 B
What is the all time high quarterly FCF for Abbott Laboratories?
Abbott Laboratories all-time high quarterly free cash flow is $3.12 B
What is Abbott Laboratories quarterly FCF year-on-year change?
Over the past year, ABT quarterly free cash flow has changed by +$832.00 M (+63.17%)
What is Abbott Laboratories TTM free cash flow?
The current TTM FCF of ABT is $6.49 B
What is the all time high TTM FCF for Abbott Laboratories?
Abbott Laboratories all-time high TTM free cash flow is $9.31 B
What is Abbott Laboratories TTM FCF year-on-year change?
Over the past year, ABT TTM free cash flow has changed by +$1.99 B (+44.39%)